Schedule 13G ownership disclosure
Lakefront Biotherapeutics NV
Security class unavailable · CUSIP: B44170106
Event date: 2018-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,427,128
- Percent of class
- 6.2900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-19-000032
- Form type
- SC 13G
- Filer
- GALAPAGOS NV
- CIK
- CIK 1421876
- Filed
- Feb 12, 2019
- Reporting period
- Dec 31, 2018
- Description
- Schedule 13G beneficial ownership